Skip to content

Observation on the Interventional Effect of Improved Moxibustion on Turtle Shell and Balanced Cupping Therapy on Patients with Primary Dysmenorrhea

Observation on the Interventional Effect of Improved Moxibustion on Turtle Shell and Balanced Cupping Therapy on Patients with Primary Dysmenorrhea

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000677
Enrollment
Unknown
Registered
2025-04-07
Start date
2024-11-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea

Interventions

Cupping and moxibustion group (Observation Group A):Cupping therapy
Moxibustion group (Observation Group B):Modified Turtle Shell Moxibustion
Balanced cupping set (control group):Balanced cupping

Sponsors

Nanjing Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
11 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Meets the diagnostic criteria for primary dysmenorrhea with symptoms of dysmenorrhea or associated symptoms occurring for at least 3 menstrual cycles. 2. Female aged between 11 to 45 years old. 3. Good compliance able to cooperate with the collection of clinical data and willing to accept this therapy. 4. Not complicated with other internal or surgical diseases. 5.Has not received other related treatments in the 3 months prior to treatment and the patient voluntarily signs an informed consent form..

Exclusion criteria

Exclusion criteria: 1. Does not meet the diagnostic criteria of traditional Chinese or Western medicine. 2. Patients under 11 years of age or over 45 years of age. 3.Patients with dysmenorrhea caused by organic lesions such as pelvic inflammatory disease confirmed by examination. 4. Patients with severe cardiovascular and cerebrovascular diseases and other primary diseases that may endanger life. 5.Patients with mental illnesses infectious diseases skin diseases skin damage rashes or other conditions that are not suitable for treatment. 6.Patients who are receiving other treatments simultaneously..

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS);COX dysmenorrhea symptom scale;Menstrual cramp symptom scoring criteria;

Secondary

MeasureTime frame
PGE2;PGF2a;

Countries

China

Contacts

Public ContactZhang Xiaoxue

Nanjing Hospital of Chinese Medicine

157860199@qq.com18951755357

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026